Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A kind of pharmaceutical composition for treating premature ovarian failure and its application

A premature ovarian failure and composition technology, which is applied in the field of pharmaceutical compositions for the treatment of premature ovarian failure, can solve the problems of endometrial cancer and breast cancer, difficult treatment, and side effects, so as to improve the disorder of sex hormones and restore the function of the gonadal axis , Improve the effect of reactivity

Active Publication Date: 2019-03-19
YABAO PHARMA GRP CO LTD
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The etiology and pathogenesis of premature ovarian failure are complex, and the treatment is extremely difficult
At present, most of the Chinese patent medicines in clinical treatment are nourishing kidney and nourishing yin, menstruation regulating medicines, such as Zuogui Pills, Dingkun Pills, etc. There are no medicines for premature ovarian failure; Western medicines mainly use estrogen and progesterone medicines, which are effective, but have side effects Large, prone to endometrial cancer and breast cancer

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of pharmaceutical composition for treating premature ovarian failure and its application
  • A kind of pharmaceutical composition for treating premature ovarian failure and its application
  • A kind of pharmaceutical composition for treating premature ovarian failure and its application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] Embodiment 1: Powder

[0033] Ligustrum lucidum 516g Northern Radix Ginseng 207g Rehmannia glutinosa 129g Salvia miltiorrhiza 387g Rubia 387g

[0034] Plum Blossom 52g Cuscuta 129g Honeysuckle 465g Chinese Rose 258g Licorice 52g

[0035] Take the above-mentioned raw materials, add conventional auxiliary materials, and make a powder according to a conventional process.

Embodiment 2

[0036] Embodiment 2: oral liquid

[0037] Ligustrum lucidum 207g Northern ginseng 516g Rehmannia glutinosa 387g Salvia miltiorrhiza 129g Rubia 129g

[0038] Plum blossom 310g Cuscuta 361g Honeysuckle 207g Chinese rose 26g Licorice 310g

[0039] The above-mentioned raw materials are taken, added with conventional auxiliary materials, and prepared into an oral liquid according to a conventional process.

Embodiment 3

[0040] Embodiment 3: pill

[0041] Ligustrum lucidum 646g, Northern Radix Ginseng 129g, Rehmannia glutinosa 52g, Salvia miltiorrhiza 387g, Rubia 387g

[0042] Plum blossom 26g Cuscuta 52g Honeysuckle 594g Chinese rose 284g Licorice 26g

[0043] Get the above-mentioned raw materials, add conventional auxiliary materials, and make pills according to conventional processes.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pharmaceutical composition for treating premature ovarian failure. The pharmaceutical composition is prepared from glossy privet fruits, radix glehniae, prepared rehmannia root, the root of red-rooted salvia, madder and the like, is under the guidance of the traditional Chinese medicines theory, starts from an overall perspective, and treats by adopting TCM therapy; through multi-system and multi-link whole regulation effect, the pharmaceutical composition can obviously mobilize the overall function, improve the reactivity of ovary for gonadotropin, and recover and improve the ovarian function; compared with the intervening measure aiming at the reduction of the estrogen level and only adopting Western medicine, the pharmaceutical composition has obvious advantages, and meanwhile, the untoward effects and the dependency caused by sex hormones can be avoided, the function of the gonad axis is recovered, the turbulence state of sex hormone is improved, and repair of ovary and other injured tissues is directly excitated.

Description

field of invention [0001] The invention relates to a pharmaceutical composition, in particular to a pharmaceutical composition for treating premature ovarian failure. Background technique [0002] In recent years, premature ovarian failure has gradually become a common and frequently-occurring disease in gynecological clinics, and has received extensive attention from all walks of life. The etiology and pathogenesis of premature ovarian failure are complex and extremely difficult to treat. At present, Chinese patent medicines in clinical treatment are mainly nourishing kidney and nourishing yin, regulating menstruation, such as Zuogui Pills, Dingkun Pills, etc. There are no medicines for premature ovarian failure; western medicines mainly use estrogen and progesterone medicines, which are effective, but have side effects Large, easy to cause endometrial cancer and breast cancer. Contents of the invention [0003] The purpose of the present invention is to provide a pharm...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/804A61P15/08
Inventor 任武贤周海燕李明军辛艳赵建刚杨芮平陈建林
Owner YABAO PHARMA GRP CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com